Some of the content on this page has been created using generative AI.
What is it about?
This study evaluates the effectiveness of a Prostate Cancer Care Pathway (PCCP) in reducing post-biopsy waiting times and improving patient satisfaction at a high-volume tertiary center. The research compares 248 patients who went through PCCP with 150 patients from pre-PCCP implementation and during Covid-19 lockdowns. Results show that PCCP significantly reduced waiting times for biopsy results, multidisciplinary discussions, and treatment consultations. The median time from biopsy to results decreased from 21 days pre-PCCP to 15 days post-PCCP. Patient satisfaction was high, with 93.2% of participants reporting satisfaction with waiting time durations. The study concludes that implementing PCCP can effectively reduce waiting times in cancer care, potentially alleviating patient anxiety during healthcare system strain without requiring additional resources.
Featured Image
Why is it important?
This research is important because it evaluates the effectiveness of a streamlined Prostate Cancer Care Pathway (PCCP) in reducing waiting times and improving patient satisfaction in a high-volume tertiary center. Prostate cancer is a significant global health concern, and delays in diagnosis and treatment can have serious consequences for patients. By demonstrating the benefits of implementing a structured care pathway, this study provides valuable insights into how healthcare systems can improve efficiency and patient outcomes, even under challenging circumstances such as the COVID-19 pandemic. The findings have broader implications for cancer care and other medical conditions, showing how streamlining resources and processes can alleviate patient anxiety and enhance overall care delivery. Key Takeaways: 1. Reduced Waiting Times: The implementation of PCCP significantly decreased waiting times for biopsy results and treatment discussions, demonstrating the effectiveness of streamlined care pathways in improving efficiency without requiring additional resources. 2. Patient Satisfaction: The study reported high levels of patient satisfaction with the PCCP, with over 93% of participants expressing satisfaction with waiting time durations, highlighting the positive impact of reduced delays on patient experience. 3. Adaptability to Healthcare Challenges: The PCCP's success in reducing waiting times even after significant COVID-19 related delays suggests that similar pathways could be adapted in other healthcare settings to improve care delivery during times of system strain or external stressors.
AI notice
Read the Original
This page is a summary of: Optimising prostate cancer pathways: Improving post‐biopsy waiting times in a tertiary centre, BJUI Compass, July 2025, Wiley,
DOI: 10.1002/bco2.70045.
You can read the full text:
Contributors
Be the first to contribute to this page







